Shannon Connelly | Authors


Bekaii-Saab Considers TKI Therapy to Treat Patients With Advanced GI Cancers

June 13, 2019

During a recent Targeted Oncology live case-based peer perspectives presentation, Tanios Bekaii-Saab, MD, discussed with a group of physicians the treatment options for patients with gastrointestinal cancers and the characteristics that influence his decision making. Bekaii-Saab explained his clinical decisions based on the case scenario of one patient with colorectal cancer and one with hepatocellular carcinoma.

Anti-PD-L1 Therapy May Have Benefit in Aggressive Papillary Thyroid Cancer

May 29, 2019

Patients with aggressive papillary thyroid cancer may be good candidates for treatment with anti–PD-(L)1 immunotherapy due to elevated levels of serum PD-L1, according to findings from a new study presented during the 2019 AACR-AHNS Head and Neck Cancer Conference.